PRINCESS MARTINEZ-BANGAY: Open Payments
NPI 1922490796 · ROSLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$736 in 16 payments from 10 companies in 2025. Trend: 2023 $704 · 2024 $352 · 2025 $736
Food & beverage: $546Education: $190
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $317 |
| Stemline Therapeutics Inc. | 2 | $140 |
| Alexion Pharmaceuticals, Inc. | 1 | $100 |
| Daiichi Sankyo Inc. | 2 | $36 |
| Janssen Biotech, Inc. | 1 | $33 |
| Gilead Sciences, Inc. | 1 | $28 |
| SOBI, INC | 1 | $22 |
| Merck Sharp & Dohme LLC | 1 | $21 |
| Legend Biotech USA Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
Products named: Orserdu, IMFINZI, SOLIRIS, Enhertu, ERLEADA, Trodelvy, Vonjo, WELIREG.
Industry payments across NY — which companies pay providers there.
